Consolidated Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||||||||
From non-controlled/non-affiliated investments: | ||||||||||||||
Interest income | $ 27,213,943 | $ 15,928,451 | $ 49,784,982 | $ 28,517,979 | ||||||||||
Dividend income | 465,869 | 467,467 | 914,203 | 934,934 | ||||||||||
Fee income | 66,285 | 34,392 | 144,163 | 90,003 | ||||||||||
Total investment income | 27,746,097 | 16,430,310 | 50,843,348 | 29,542,916 | ||||||||||
Expenses: | ||||||||||||||
Interest and credit facility fees | 7,112,700 | 5,703,127 | 13,266,980 | 11,003,701 | ||||||||||
Management fees | 1,691,116 | 899,154 | 3,195,349 | 1,615,906 | ||||||||||
Income incentive fee | 2,095,341 | 1,017,122 | 3,772,701 | 1,709,772 | ||||||||||
Capital gain incentive fees | 477,946 | (68,141) | 90,495 | 72,984 | ||||||||||
Professional fees | 803,476 | 622,133 | 1,833,145 | 1,222,284 | ||||||||||
Amortization of continuous offering costs | 176,479 | 405,078 | 472,216 | 704,934 | ||||||||||
Administrative services expense | 266,046 | 266,874 | 501,124 | 533,748 | ||||||||||
Amortization of deferred financing costs | 202,256 | 171,595 | 366,452 | 343,189 | ||||||||||
Directors' fees and expenses | 100,000 | 99,999 | 200,000 | 199,998 | ||||||||||
Other expenses | 194,703 | 131,047 | 386,356 | 246,652 | ||||||||||
Total expenses | 13,120,063 | 9,247,988 | 24,084,818 | 17,653,168 | ||||||||||
Expenses waived by the Advisor (Note 3) | 0 | (235,171) | (162,124) | (886,946) | ||||||||||
Net expenses | 13,120,063 | 9,012,817 | 23,922,694 | 16,766,222 | ||||||||||
Net investment income | 14,626,034 | [1] | 7,417,493 | [2],[3] | 26,920,654 | [1] | 12,776,694 | [2],[3] | ||||||
Net change in unrealized appreciation (depreciation): | ||||||||||||||
Net change in unrealized appreciation (depreciation), Non-controlled/non-affiliated investments | (1,673,696) | (912,836) | ||||||||||||
Derivative instruments (Note 5) | (371,995) | 11,637 | (1,053,020) | 11,637 | ||||||||||
Foreign currency transactions | 2,127,019 | (10,005) | 2,283,839 | (10,005) | ||||||||||
Net change in unrealized appreciation (depreciation) | 3,994,306 | [1] | (1,149,056) | [2],[3] | (442,877) | [1] | (911,204) | [2],[3] | ||||||
Realized gain (loss): | ||||||||||||||
Realized gain (loss), Non-controlled/non-affiliated investments | 1,838,528 | 1,658,790 | ||||||||||||
Derivative instruments (Note 5) | (1,083,416) | 0 | (1,083,416) | 0 | ||||||||||
Foreign currency transactions | 23,259 | (1,621) | 15,059 | (1,621) | ||||||||||
Net realized gain (loss) | (561,667) | [1] | 610,459 | [2],[3] | 770,171 | [1] | 1,657,169 | [2],[3] | ||||||
Net realized and unrealized gain (loss) | 3,432,639 | (538,597) | 327,294 | 745,965 | ||||||||||
Net increase (decrease) in net assets resulting from operations | 18,058,673 | [1] | 6,878,896 | [2],[3] | 27,247,948 | [1] | 13,522,659 | [2],[3] | ||||||
Non-controlled/Non-affiliated Investments [Member] | ||||||||||||||
Net change in unrealized appreciation (depreciation): | ||||||||||||||
Net change in unrealized appreciation (depreciation), Non-controlled/non-affiliated investments | 2,239,282 | (1,150,688) | (1,673,696) | (912,836) | ||||||||||
Realized gain (loss): | ||||||||||||||
Realized gain (loss), Non-controlled/non-affiliated investments | $ 498,490 | $ 612,080 | $ 1,838,528 | $ 1,658,790 | ||||||||||
|
X | ||||||||||
- Definition Amount of amortization expense attributable to continuous offering costs. No definition available.
|
X | ||||||||||
- Definition From non-controlled/non-affiliated investments. No definition available.
|
X | ||||||||||
- Definition Incentive fee expense (income), capital-gain-based. No definition available.
|
X | ||||||||||
- Definition Interest and credit facility fees. No definition available.
|
X | ||||||||||
- Definition Net change in unrealized appreciation (depreciation). No definition available.
|
X | ||||||||||
- Definition Realized gain (loss). No definition available.
|
X | ||||||||||
- Definition Realized gain (loss) on derivatives. No definition available.
|
X | ||||||||||
- Definition Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of amortization expense attributable to debt issuance costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of realized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of operating dividend income on securities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of fee income including, but not limited to, managerial assistance, servicing of investment, and origination and commitment fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount, before tax, of realized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, before tax, of unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for income-based incentive fee for performance under arrangement to manage operation, including, but not limited to, managing investment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of fee contractually waived by investment company. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after reimbursement and fee waiver, of expense for generation of investment income classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of expenses related to the generation of investment income. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for service provided by entity's director. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, after tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount, after tax, of realized gain (loss) on investment, derivative, and foreign currency transaction, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount, after tax, of unrealized gain (loss) on investment, derivative, and foreign currency transaction, classified as operating. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|